171 related articles for article (PubMed ID: 9517427)
1. Pharmacological characterization of N-methyl-D-aspartate receptors in spinal cord of rats with a chronic peripheral mononeuropathy.
Wei HB; Jakeman LB; Hunter JC; Bonhaus DW
Neuropharmacology; 1997; 36(11-12):1561-9. PubMed ID: 9517427
[TBL] [Abstract][Full Text] [Related]
2. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
Bhargava HN; Matwyshyn GA; Gudehithlu KP
Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of [3H]MK-801 binding in the rat spinal cord.
Souverbie F; Mo LL; Liu Y; von Euler G; Sundstr-om E
Eur J Pharmacol; 1996 Jul; 307(3):347-53. PubMed ID: 8836624
[TBL] [Abstract][Full Text] [Related]
5. Ethanol-induced inhibition of [3H]thienylcyclohexylpiperidine (TCP) binding to NMDA receptors in brain synaptic membranes and to a purified protein complex.
Michaelis EK; Chen X; Joseph DB; Hurlbert M; Kumar KN; Michaelis ML
J Neurochem; 1996 Jul; 67(1):201-11. PubMed ID: 8666993
[TBL] [Abstract][Full Text] [Related]
6. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
7. Regionally distinct stoichiometry for N-methyl-D-aspartate receptor domains in brain.
Matsunaga T; Mukhin AG; London ED
Neuroreport; 1996 Feb; 7(3):833-7. PubMed ID: 8733756
[TBL] [Abstract][Full Text] [Related]
8. Selective depression of the spinal polysynaptic reflex by the NMDA receptor antagonists in an isolated spinal cord in vitro.
Maruoka Y; Ohno Y; Tanaka H; Yasuda H; Ohtani K; Sakamoto H; Kawabe A; Tamamura C; Nakamura M
Gen Pharmacol; 1997 Oct; 29(4):645-9. PubMed ID: 9352316
[TBL] [Abstract][Full Text] [Related]
9. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
Witkin JM; Steele TD; Sharpe LG
J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine.
Bhargava HN; Reddy PL; Gudehithlu KP
Gen Pharmacol; 1995 Jan; 26(1):131-6. PubMed ID: 7713352
[TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex.
Yeh GC; Chen JC; Tsai HC; Wu HH; Lin CY; Hsu PC; Peng YC
J Pharmacol Exp Ther; 2002 Mar; 300(3):1008-16. PubMed ID: 11861810
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats.
Yashpal K; Fisher K; Chabot JG; Coderre TJ
Pain; 2001 Oct; 94(1):17-29. PubMed ID: 11576741
[TBL] [Abstract][Full Text] [Related]
14. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
15. Unique properties of [3H]MK-801 binding in membranes from the rat spinal cord.
Liu Y; Souverbie F; Sundström E; von Euler G
Brain Res; 1997 May; 757(2):167-75. PubMed ID: 9200745
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the N-methyl-D-aspartate (NMDA) receptor-channel in rodent and dog brain and rat spinal cord using [3H]MK-801 binding.
Sharif NA; Nunes JL; Whiting RL
Neurochem Res; 1991 May; 16(5):563-9. PubMed ID: 1836546
[TBL] [Abstract][Full Text] [Related]
17. Heterocarrier-mediated reciprocal modulation of glutamate and glycine release in rat cerebral cortex and spinal cord synaptosomes.
Bonanno G; Vallebuona F; Donadini F; Fontana G; Fedele E; Raiteri M
Eur J Pharmacol; 1994 Jan; 252(1):61-7. PubMed ID: 7908643
[TBL] [Abstract][Full Text] [Related]
18. Spinal N-methyl-d-aspartate receptors may contribute to the immobilizing action of isoflurane.
Stabernack C; Sonner JM; Laster M; Zhang Y; Xing Y; Sharma M; Eger EI
Anesth Analg; 2003 Jan; 96(1):102-7, table of contents. PubMed ID: 12505933
[TBL] [Abstract][Full Text] [Related]
19. Effect of spinal cord transection on N-methyl-D-aspartate receptors in the cord.
Krenz NR; Weaver LC
J Neurotrauma; 1998 Dec; 15(12):1027-36. PubMed ID: 9872459
[TBL] [Abstract][Full Text] [Related]
20. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.
Ebert B; Mikkelsen S; Thorkildsen C; Borgbjerg FM
Eur J Pharmacol; 1997 Aug; 333(1):99-104. PubMed ID: 9311667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
